Leqembi’s benefits continue to improve with longer use, study finds
By
Kristen Fischer
Jul 31, 2024
People with early-stage Alzheimer’s disease who take Leqembi can experience more benefits if they stay on it for three years, a new study shows.
Study: Having two copies of gene mutation linked to Alzheimer’s may cause onset
By
Kristen Fischer
May 07, 2024
A new study finds that possessing two copies of a specific gene mutation that’s common in Alzheimer’s disease may be the cause behind the disease in those people.